This prospective, open study was carried out in order to assess changes in the swallowing and dietary status after injection of Botulinum toxin A (BoNT-A) into the upper esophageal sphincter (UES) in a series of patients with cricopharyngeus (CP) muscle dysfunction associated with pharyngo-laryngeal weakness during at least 1 year follow-up after treatment. Patients who had a cricopharyngeus (CP) muscle dysfunction associated with pharyngo-laryngeal weakness and who were at risk for aspiration were included in the study. The upper border of the cricoid cartilage was identified and the CP muscle localized using a standard electromyogram (EMG). The dose of BoNT-A was determined depending on the results of EMG performed just before the injection. Outcomes were assessed by the penetration-aspiration scale (PAS), the level of residue in the pyriform sinus and the National Institute of Health-Swallow Safety Scale (NIH-SSS) on a video fluoroscopic swallowing (VFSS) assessment, the patient's subjective impressions of their ability to swallow by the Deglutition Handicap Index (DHI), and changes in dietary status by the Functional Oral Intake Scale. Eleven patients underwent the complete assessment of swallowing function at 1, 3, 6, and 12 months. After the first set of treatment, seven patients had a good response and four did not respond. A significant decrease in the PAS score (p = 0.03), the amount of residue (p = 0.04) and the NIH-SSS score (p = 0.03) was observed 3 months after the injection in comparison with the first VFSS before the treatment. A relapse of dysphagia occurred in 3 out of the 11 treated patients; at 3 and 4 months for 2 patients with a Wallenberg syndrome, and at 11 months for a patient with cranial nerve paralysis after a surgery for a glomus tumor. Two of them underwent a second injection. One patient had a good response and remained stable for at least 1 year. The second did not respond either to the second injection or to a myotomy of the cricopharyngeal muscle. The third one is waiting for further surgery (myotomy). Therefore, at the end of the study and after a follow-up of at least 12 months, 5 patients out of the 11 enrolled had a good result. Percutaneous injection of BoNT-A into the UES can be a useful solution to improve cricopharyngeal dysfunction, despite the underlying pharyngo-laryngeal weakness.
vement plus grande pour la condition VI ou VM que pour la condition VN. Le passage de la condition VN à la condition VI augmente le taux de satisfaction des auditeurs quant à l'intelligibilité de 78 à 87% pour Mme B et de 46 à 63% pour Mme Z. Les erreurs sont moins fréquentes avec la compression pour Mme Z. L'effet de l'accéléra-tion n'est jamais significatif sur les temps de réaction (F 2, 1024 = 2,14, p = 0,12). Conclusions: Cette étude est la première à analyser l'effet d'une accélération temporelle uniforme sur de la parole pathologique. Elle montre que chez 2 patientes présentant une dysarthrie ataxique, le niveau perçu de l'intelligibilité est amélioré. The Effect of Time-Compressed Speech on the Perception of Ataxic Dysarthria: A Report of Two CasesAim: In cerebellar dysarthria, the lack of precision in the articulatory motions leads to a temporal dysregulation with a decreased rate of speech. That is, our hypothesis is that the signal distortions are linked to the slowness of speech and that the acceleration of the rate improves the intelligibility of speech. Patients and Method: Two patients with a cerebellar pathology and an ataxic dysarthria participated in the present study. Speech intelligibility was assessed subjectively by a visual analog scale, and objectively by the constant-stimulus method associated with an identification task of a target phoneme in real time. The SOLA algorithm was used to accelerate the speech stimuli. 144 test sentences were created at 3 speed rates: 48 sentences at 'natural speed' (without compression, VN), 48 sentences at 'intermediate speed' (50% of the maximum rate, VI) and 48 sentences at 'maximum speed' (mean rate of a control group of speakers, VM). The 144 test sentences, in 3 experimental conditions, were distributed over 3 lists, each listener hearing each sentence only once; 8 subjects were assigned to each list. The sentences were presented in random order. A subjective assessment was performed
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.